• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Diagnostics

Patent board invalidates RainDance patent for obviousness

January 20, 2017 By Sarah Faulkner

The Patent Trial and Appeal Board invalidated a RainDance Technologies patent earlier this week for obviousness. The patent, which covers a method for manipulating the size of liquid droplets used in microfluidic diagnostic tests, was challenged by manufacturer 10X Genomics Inc. The panel, after conducting an inter partes review, found that the technique’s characteristics, which […]

Filed Under: Diagnostics, Featured, Legal News, Wall Street Beat Tagged With: 10X Genomics, Bio-Rad Laboratories, RainDance Technologies

Bio-Rad Laboratories to acquire RainDance Technologies

January 17, 2017 By Sarah Faulkner

Bio-Rad Laboratories (NYSE:BIO) said yesterday that it inked a definitive agreement to acquire RainDance Technologies for an undisclosed amount. The Hercules, Calif.-based company said it expects the transaction to close in the 1st quarter of 2017 and that it will reveal the terms of the acquisition when it discusses its 4th quarter and full-year financial […]

Filed Under: Diagnostics, Featured, Wall Street Beat Tagged With: Bio-Rad Laboratories, RainDance Technologies

Bracco Diagnostics wins another FDA nod for Lumason microspheres

January 12, 2017 By Sarah Faulkner

Bracco

Bracco Imaging U.S. subsidiary Bracco Diagnostics said today that it won FDA approval for its Lumason microsphere contrast agent to be used in ultrasonography of the urinary tract in pediatric patients with suspected or known vesicoureteral reflux. “The approval of Lumason for voiding ultrasonography answers an unmet medical need for an effective imaging study to […]

Filed Under: Diagnostics, Featured, Imaging, Pediatrics Tagged With: Bracco Diagnostics

Grifols pays $51m for minority stake in Access Biologicals

January 12, 2017 By Brad Perriello

biologics

Grifols (NSDQ:GRFS) said today that it paid $51 million for a 49% stake in Access Biologicals, in a deal that includes an option to acquire the rest of the business. That option, for the remaining 51% share in Vista, Calif.-based Access, goes live in 2022, Grifols said. The agreement also includes a provision to supply Access with non-human-use […]

Filed Under: Diagnostics, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat Tagged With: Access Biologicals, Grifols

FDA warns on MRI risks with infusion pumps

January 12, 2017 By Sarah Faulkner

FDA

The FDA issued a warning today that the strong magnetic fields used in an MRI exam can affect implantable infusion pumps. The federal watchdog has received reports of serious adverse events, including patient death, associated with using an infusion pump in an MR environment. The reports claim that some patients have experienced inaccurate medication dosing […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Hospital Care, Imaging, Pharmaceuticals

Navidea deals NA Lymphoseek rights to Cardinal Health in $310m deal

November 28, 2016 By Sarah Faulkner

Navidea Biopharmaceuticals (NYSE:NAVB) said today that it inked a definitive asset purchase agreement with Cardinal Health (NYSE:CAH) for its Lymphoseek product. Dublin, Ohio-based Navidea said it’s due to receive $80 million at closing for the lymphatic mapping and lymph node biopsy product, plus the opportunity for $230 million in milestone payments through 2026. More than $20 […]

Filed Under: Diagnostics, Featured, Mergers & Acquisitions, Oncology, Wall Street Beat Tagged With: Cardinal Health, Navidea Biopharmaceuticals

Handheld breathalyzer as noninvasive blood glucose monitor in development

November 15, 2016 By Sarah Faulkner

Handheld breathalyzer as noninvasive blood glucose monitor in development

Researchers from the Western New England University developed a device the size of a small book that diabetes patients can use to monitor their blood glucose levels. Unlike traditional finger-stick testing, this minimally invasive breathalyzer uses acetone levels in patients’ breath to determine blood glucose levels. The team, led by Ronny Priefer and Michael Rust, presented […]

Filed Under: Clinical Trials, Diabetes, Diagnostics, Featured, Research & Development Tagged With: Western New England University

Acoustic waves used to move fluid through nanoscale channels

November 15, 2016 By Sarah Faulkner

Acoustic waves used to move fluid through nanoscale channels

Researchers from the University of California San Diego used acoustic waves to move fluids through small channels, marking the 1st time that surface acoustic waves have been used at the nanoscale. The team’s work was published this week in Advanced Functional Materials.  The findings are an important step towards manufacturing small, portable devices for drug discovery […]

Filed Under: Diagnostics, Featured, Nanoparticles, Research & Development Tagged With: University of California San Diego

Hologic inks collab deal with Seegene

November 8, 2016 By Sarah Faulkner

Hologic, Seegene

Seegene (KSDQ:096530) said today that it inked a collaboration deal with Hologic (NSDQ:HOLX) to develop high-multiplex, real-time PCR reagents for the developing Hologic Panther Fusion system. According to the agreement, Seegene will develop and manufacture multiplex assays for Hologic’s next-gen molecular diagnostics platform; Hologic will receive worldwide commercialization rights to the assays. Financial terms of the deal were […]

Filed Under: Diagnostics, Featured, Research & Development Tagged With: Hologic Diagnostics, Seegene

Lumicell adds another $600,000 in funding

March 6, 2014 By drugdelivery

Lumicell secures over $1M in funding round

Imaging systems maker Lumicell Diagnostics amended a previously closed $1 million funding round after landing another $560,000 in financing from 2 new investors, regulatory filings show.

Filed Under: Diagnostics, Drug-Device Combinations Tagged With: Lumicell

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS